NVO
Novo Nordisk A/S
Stock
$37.32−0.08 (−0.21%)Close Oct 2, 2026
- Research and development, 2025
- DKK 52.0B
- YoY, 2025
- +8.3%
- 5-year CAGR
- +27.5%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | DKK 52.0B | +8.3% |
| 2024 | DKK 48.1B | +48.1% |
| 2023 | DKK 32.4B | +34.9% |
| 2022 | DKK 24.0B | +35.3% |
| 2021 | DKK 17.8B | +14.9% |
| 2020 | DKK 15.5B | +8.7% |
| 2019 | DKK 14.2B | — |